In the past 20 trading days (about 1 month), China real estate stocks have performed very well. Vanke (2202) and Longfor (0960) performed best among large-cap stocks, rising 61.8% and…
Posts published in “HK Stock Analysis”
● Hang Seng rose 5 days in a row with a total gain of +8.8% ● +8.8% is the best weekly % gain in 652 weeks since 2011-10-28 Fri ●…
Recently, HSI rebounded from the white trading range bottom. at the same time, the daily RSI bounced off the yellow down trendline. HSI clearly broke through the purple down channel…
The Hang Seng Index (HSI) recently regained the orange up trendline and broke above the purple down channel top that had persisted for over a year, but quickly retreated, suggesting…
The Shanghai Composite Index (SSEC) met resistance at the MA200 and the purple downtrend line, slightly falling below the 3,000-point mark and the 19-year light blue uptrend line from 2005.…
The Hang Seng Index (HSI) is testing the 50-day moving average and two orange trend lines, and they had better stand their ground. On the upside, major resistance is at…
The Hong Kong Growth Enterprise Market (GEM) index has plummeted -99.46% over the past 23 years, dropping from 3286.95 points on January 23, 2001, to 17.86 points on March 4,…
China Securities Regulatory Commission (CSRC) stated in the evening on the 5th that amid recent stock market volatility, there were ‘unlawful elements’ engaged in ‘illegal profiteering.’ Multiple cases of ‘market…
In 2023, the CCL Index experienced a -5.22% decline to 148.59, marking an -11.76% drop from the mid-April rebound high. Anticipated support for CCL is identified at the intersection of…
SINO BIOPHARM (1177.HK) met resistance at the orange downtrend line, MA50 and the purple horizontal line. It needs to recover all these to confirm the end of the downtrend. 360miq.com/stockinfo?code=1177.HK